France Viral Vaccines Cdmo Market Size & Outlook, 2025-2033

The viral vaccines cdmo market in France is expected to reach a projected revenue of US$ 262.5 million by 2033. A compound annual growth rate of 14.3% is expected of France viral vaccines cdmo market from 2025 to 2033.
Revenue, 2024 (US$M)
$83.8
Forecast, 2033 (US$M)
$262.5
CAGR, 2025 - 2033
14.3%
Report Coverage
France

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France viral vaccines cdmo market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France viral vaccines cdmo market highlights

  • The France viral vaccines cdmo market generated a revenue of USD 83.8 million in 2024 and is expected to reach USD 262.5 million by 2033.
  • The France market is expected to grow at a CAGR of 14.3% from 2025 to 2033.
  • In terms of segment, attenuated vaccine was the largest revenue generating type in 2024.
  • Subunit Vaccines is the most lucrative type segment registering the fastest growth during the forecast period.


Viral vaccines cdmo market data book summary

Market revenue in 2024USD 83.8 million
Market revenue in 2033USD 262.5 million
Growth rate14.3% (CAGR from 2025 to 2033)
Largest segmentAttenuated vaccine
Fastest growing segmentSubunit Vaccines
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAttenuated Vaccine, Inactivated Vaccine, DNA Vaccines, Subunit Vaccines
Key market players worldwideLonza Group Ltd, Catalent Pharma Solutions, Thermo Fisher Scientific, Inc., Alcami, Samsung BioLogics, FUJIFILM Diosynth Biotechnologies, WuXi Biologics., Recipharm AB, HALIX, Batavia Biosciences


Other key industry trends

  • In terms of revenue, France accounted for 3.8% of the global viral vaccines cdmo market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany viral vaccines cdmo market is projected to lead the regional market in terms of revenue in 2033.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 429.7 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viral Vaccines CDMO Market Companies

Name Profile # Employees HQ Website
FUJIFILM Diosynth Biotechnologies View profile - - -
Recipharm AB View profile - - -
WuXi Biologics. View profile - - -
Thermo Fisher Scientific, Inc. View profile - - -
Catalent Pharma Solutions View profile 5001-10000 Somerset, New Jersey, United States, North America http://www.catalent.com
HALIX View profile 11-50 Leiden, Zuid-Holland, The Netherlands, Europe https://www.halix.nl
Batavia Biosciences View profile 101-250 Leiden, Zuid-Holland, The Netherlands, Europe http://www.bataviabiosciences.com/
Alcami View profile 501-1000 Wilmington, North Carolina, United States, North America http://www.alcaminow.com
Samsung BioLogics View profile 1001-5000 Incheon, Inch'on-jikhalsi, South Korea, Asia https://www.samsungbiologics.com/
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com

France viral vaccines cdmo market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vaccines cdmo market will help companies and investors design strategic landscapes.


Attenuated vaccine was the largest segment with a revenue share of 40.93% in 2024. Horizon Databook has segmented the France viral vaccines cdmo market based on attenuated vaccine, inactivated vaccine, dna vaccines, subunit vaccines covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to France viral vaccines cdmo market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France viral vaccines cdmo market databook

  • Our clientele includes a mix of viral vaccines cdmo market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France viral vaccines cdmo market , including forecasts for subscribers. This country databook contains high-level insights into France viral vaccines cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France viral vaccines cdmo market size, by type, 2021-2033 (US$M)

France Viral Vaccines CDMO Market Outlook Share, 2024 & 2033 (US$M)

France viral vaccines cdmo market size, by type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online